World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
147
Citations
135283
World Ranking
1246
National Ranking
723

Daniel A. Haber publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Daniel A. Haber sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 454 publications — 50th percentile

50% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Daniel A. Haber D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Daniel A. Haber sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 147 D-Index — 94th percentile

94% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Daniel A. Haber is affiliated with Harvard University in the United States. Their research spans multiple fields within biomedical science, focusing primarily on medicine and biochemistry, genetics, and molecular biology. The scientist has contributed extensively to oncology, molecular biology, cancer research, pulmonary and respiratory medicine, and biomedical engineering.

Their research topics cover a broad range of cancer-related areas, including:

  • Cancer Genomics and Diagnostics
  • Cancer Cells and Metastasis
  • Advanced Breast Cancer Therapies
  • Microfluidic and Bio-sensing Technologies
  • Lung Cancer Treatments and Mutations
  • RNA modifications and cancer
  • RNA Interference and Gene Delivery

Some of the recent significant publications by Daniel A. Haber include:

  • Integrating genomic features for non-invasive early lung cancer detection, 2020, Nature
  • Deregulation of ribosomal protein expression and translation promotes breast cancer metastasis, 2020, Science
  • The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis, 2020, Cancer Discovery
  • Ultrahigh-throughput magnetic sorting of large blood volumes for epitope-agnostic isolation of circulating tumor cells, 2020, Proceedings of the National Academy of Sciences
  • RNA transcripts stimulate homologous recombination by forming DR-loops, 2021, Nature

Frequent co-authors associated with Daniel A. Haber include:

  • Shyamala Maheswaran
  • Mehmet Toner
  • Taronish D. Dubash
  • Ben S. Wittner
  • Aditya Bardia

The scientist's work has been published repeatedly in several venues, reflecting their areas of focus. Frequent publication venues include:

  • Cancer Research
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Cancer Research
  • Nature Communications
  • Proceedings of the National Academy of Sciences

Overall, Daniel A. Haber's research provides insights into various aspects of cancer biology and treatment, leveraging molecular biology techniques and diagnostic innovations, particularly in the context of lung and breast cancers. Their collaborations and scholarly output illustrate an interdisciplinary approach to addressing complex biomedical challenges.

Best Publications

  • Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

    Thomas J Lynch;Daphne W Bell;Raffaella Sordella;Sarada Gurubhagavatula

  • DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

    Masaki Okano;Daphne W Bell;Daniel A Haber;En Li

  • Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer

    Eunice L. Kwak;Yung-Jue Bang;D. Ross Camidge;Alice T. Shaw

  • Isolation of rare circulating tumour cells in cancer patients by microchip technology.

    Sunitha Nagrath;Lecia V. Sequist;Shyamala Maheswaran;Daphne W. Bell;Daphne W. Bell

  • Epidermal growth factor receptor mutations in lung cancer

    Sreenath V. Sharma;Daphne W. Bell;Daphne W. Bell;Jeffrey Settleman;Daniel A. Haber

  • Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells

    Wanjuan Yang;Jorge Soares;Patricia Greninger;Elena J. Edelman

  • Systematic identification of genomic markers of drug sensitivity in cancer cells

    Mathew J. Garnett;Elena J. Edelman;Sonja J. Heidorn;Christopher Greenman;Christopher Greenman

  • Circulating Breast Tumor Cells Exhibit Dynamic Changes in Epithelial and Mesenchymal Composition

    Min Yu;Aditya Bardia;Ben S. Wittner;Shannon L. Stott

  • hEST2, the Putative Human Telomerase Catalytic Subunit Gene, Is Up-Regulated in Tumor Cells and during Immortalization

    Matthew Meyerson;Christopher M Counter;Elinor Ng Eaton;Leif W Ellisen

  • Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus.

    Katherine M. Call;Thomas M Glaser;Caryn Y. Ito;Alan J. Buckler

  • Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

    Nicola Aceto;Aditya Bardia;David T. Miyamoto;Maria C. Donaldson

  • A Landscape of Pharmacogenomic Interactions in Cancer

    Francesco Iorio;Francesco Iorio;Theo A. Knijnenburg;Theo A. Knijnenburg;Daniel J. Vis;Graham R. Bignell

  • Detection of Mutations in EGFR in Circulating Lung-Cancer Cells

    Shyamala Maheswaran;Lecia V. Sequist;Sunitha Nagrath;Lindsey Ulkus

  • Gefitinib-Sensitizing EGFR Mutations in Lung Cancer Activate Anti-Apoptotic Pathways

    Raffaella Sordella;Daphne W. Bell;Daniel A. Haber;Jeffrey Settleman

  • Isolation of circulating tumor cells using a microvortex-generating herringbone-chip

    Shannon L. Stott;Chia Hsien Hsu;Chia Hsien Hsu;Chia Hsien Hsu;Dina I. Tsukrov;Min Yu

  • Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

    Vasanthi S. Viswanathan;Matthew J. Ryan;Harshil D. Dhruv;Shubhroz Gill

  • Circulating tumor cells: approaches to isolation and characterization

    Min Yu;Shannon Stott;Mehmet Toner;Shyamala Maheswaran

  • Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinib

    Eunice L. Kwak;Raffaella Sordella;Daphne W. Bell;Nadia Godin-Heymann

  • Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.

    Daphne W. Bell;Jennifer M. Varley;Tara E. Szydlo;Deborah H. Kang

  • Inertial Focusing for Tumor Antigen–Dependent and –Independent Sorting of Rare Circulating Tumor Cells

    Emre Ozkumur;Ajay M. Shah;Jordan C. Ciciliano;Benjamin L. Emmink

Frequent Co-Authors

Shyamala Maheswaran
Shyamala Maheswaran Harvard University
Mehmet Toner
Mehmet Toner Harvard University
Jeffrey Settleman
Jeffrey Settleman Pfizer (Germany)
David T. Ting
David T. Ting Harvard University
Lecia V. Sequist
Lecia V. Sequist Harvard University
Sridhar Ramaswamy
Sridhar Ramaswamy Harvard University
Aditya Bardia
Aditya Bardia Harvard University
Miguel Rivera
Miguel Rivera Harvard University
Dennis C. Sgroi
Dennis C. Sgroi Harvard University
Matthew Meyerson
Matthew Meyerson Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering Medicine in the USA, many related degrees and alternative pathways can broaden your skills and career prospects. For healthcare professionals aiming to advance, affordable dnp programs offer flexible options to reach the highest level of nursing practice.

Those seeking entry into the nursing field may prefer a quicker route through a fast lpn program. These programs typically offer accelerated courses, allowing students to join the workforce sooner and start gaining invaluable hands-on experience.

Nurses with a Bachelor of Science in Nursing can enhance their credentials conveniently with bsn to np programs online. These programs are ideal for those who want to become Nurse Practitioners in specialized fields like psychiatric mental health, often with the flexibility of online study.

For those interested in the business and leadership side of healthcare, pursuing a health care administration degree online can open doors to management roles in hospitals, clinics, and beyond. Each of these options can complement or serve as alternatives to traditional medical degrees.

Best Scientists Citing Daniel A. Haber

Trending Scientists

Recently Published Articles